-
NextBillion’s (First) Market Dynamics E-book: A compilation of posts from the first year of our initiative
The market – the same supply and demand interplay that has helped create order and prosperity in the developed world – is failing to serve health care in the developing world. That’s why “market dynamics” has become a term du jour in global health, and why NextBillion Health Care in spring 2014 launched an initiative aimed to exploring the concept. Now we’ve added an e-book.
- Categories
- Health Care
- Tags
- vaccines
-
Press Release: Global Health Partners Begin Building a New Approach to Ensure Equitable Access to Medicines
Global health partners met in Geneva to begin the process of building a new approach to better determine health needs and constraints and addressing them in countries.
- Categories
- Health Care
- Region
- Europe & Eurasia
-
Viewpoint: $7.5 Billion on the Table for Vaccines: Will Leaders Keep Their Word?
What happens when the cameras power down, the microphones are put away, and the jets take off That’s a question many citizens ask themselves when they see their leaders in the headlines, making a fiery speech or a bold pledge from a podium in a faraway city.
- Categories
- Health Care
- Tags
- vaccines
-
Big Pharma, NGO Square the Circle on Access to Vaccines
One would expect a multinational pharmaceutical group and a leading humanitarian NGO to hold radically opposed views on access to vaccines.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Can Too Many Free and Subsidized Condoms Actually Harm Markets?
In Myanmar, sexual encounters are the most common mode of HIV transmission, causing the epidemic to concentrate among key populations such as female sex workers (FSW) and their male clients (MC), as well as men who have sex with men (MSM). Since 1996, PSI/Myanmar has targeted its condom social marketing program to these groups in order to achieve the greatest impact by preventing the spread of infection.
- Categories
- Health Care
- Region
- South Asia
-
Tuberculosis Drug Candidate Begins Clinical Safety Trial
The first clinical safety trial on a tuberculosis drug since 2009 is now under way. The phase I trial of TBA-354 will involve 50 volunteers from the United States, according to the TB Alliance, the not-for-profit product development partnership sponsoring the trial.
- Categories
- Health Care
-
World Trade Organization Least-Developed Countries Request Waiver of Intellectual Property Rights on Pharma Products
This week at the World Trade Organization intellectual property committee meeting, least-developed countries submitted a request to extend a waiver allowing them not to enforce intellectual property rights on pharmaceutical products. The countries have extended the waiver before, but this time they are seeking to make it indefinite, until they are no longer considered LDCs.
- Categories
- Health Care
-
Merck Places Children’s HIV Drug in Shared Non-Profit Patent Pool
U.S. drugmaker Merck & Co has contributed an HIV medicine for children to an international shared patent pool in a move that should speed the development of cheap paediatric formulations for use in poor countries.
- Categories
- Health Care
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.